The Cultivation of College Students' Social Behavior in Public Physical Education Courses in Colleges and Universities: A Study Based on the Experiential Learning Model

February 6, 2026 updated by: Han Xu
This study adopts a quasi-experimental design and plans to recruit 94 university students from a university in Jiangsu Province, randomly divided into an experimental group and a control group. The experimental group will receive tennis courses based on the experiential learning model, with one 90-minute class each week. The course content will combine tennis skill training and social interaction activities that promote cooperation. The control group will continue with conventional tennis teaching. The study will include baseline testing, teaching intervention, and post-intervention assessment. The main measurement indicators will include prosocial behavior and physical fitness. Prosocial behavior will be evaluated using the PABSS Chinese version questionnaire, which includes aspects such as prosocial behavior toward teammates and opponents, antisocial behavior, and teamwork spirit. Physical fitness will be assessed using the physical fitness test and the CAPL-2 Chinese version questionnaire. Independent samples t-test, paired samples t-test, two-way analysis of variance (ANOVA), and analysis of covariance (ANCOVA) will be used to analyze the differences in prosocial behavior and physical fitness between the experimental and control groups.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Completed

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Interventional

Enrollment (Actual)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
94

Phase

Phase

The stage of a clinical trial studying a drug or biological product, based on definitions developed by the U.S. Food and Drug Administration (FDA). The phase is based on the study's objective, the number of participants, and other characteristics. There are five phases: Early Phase 1 (formerly listed as Phase 0), Phase 1, Phase 2, Phase 3, and Phase 4. Not Applicable is used to describe trials without FDA-defined phases, including trials of devices or behavioral interventions.
  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • China
    • Jiangsu
      • Yangzhou, Jiangsu, China, 225000
        • Yangzhou University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  1. Participants are university students aged between 18 and 22 years who are capable of safely participating in physical activities and have no health risks.
  2. Students must be able to communicate effectively, understand, and sign the informed consent form.
  3. Students must be willing to participate in an 8-week intervention (once a week, 90 minutes per session) and be able to withdraw from the study at any time.
  4. Participants must be able to complete all the teaching activities and have no physical or psychological conditions that limit their full participation in physical activities.
  5. All participants are from the agreed university in Jiangsu to ensure consistency in the environment and reduce external interference.
  6. All participants must agree to follow the study rules and participate in the research.

Exclusion Criteria:

  1. Students with physical or psychological health conditions that prevent safe participation in physical activities.
  2. Students who are unable to communicate effectively or cannot understand the informed consent form.
  3. Students who are unable to attend the full 8-week intervention (once a week, 90 minutes per session).
  4. Students who withdraw from the study or do not complete the course during the research period.
  5. Students with serious illnesses or health risks will be excluded from the study.
  6. Factors such as family socio-economic status, academic performance, or participation in physical activities that could potentially affect the results will be used as exclusion criteria.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm

Participant Group / Arm

A group or subgroup of participants in a clinical trial that receives a specific intervention/treatment, or no intervention, according to the trial's protocol.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
Experimental: Experimental Group: Tennis Course Based on Experiential Learning Model
The experimental group will participate in a tennis course based on the experiential learning model. The course will involve 90-minute weekly sessions, focusing on tennis skill development and social interaction activities designed to promote cooperation and enhance prosocial behavior among students. This intervention aims to foster teamwork, social responsibility, and collective spirit through sports.
Behavioral: experiential learning model
The intervention in this study consists of a tennis course based on the experiential learning model, with one 90-minute class per week. The course includes tennis skill training and social interaction activities that promote cooperation. Compared to conventional physical education courses, this course focuses on enhancing students' collectivism and social responsibility through cooperation and competition in sports.
Active Comparator: Control Group: Regular Tennis Course
The control group will continue with the regular tennis course, focusing solely on tennis skill development without incorporating the experiential learning model. The course will follow the standard physical education curriculum without additional social interaction activities aimed at enhancing prosocial behavior or cooperation.
Behavioral: Regular Tennis Course
The control group will continue with the regular tennis course, focusing solely on tennis skill development without incorporating the experiential learning model. The course will follow the standard physical education curriculum without additional social interaction activities aimed at enhancing prosocial behavior or cooperation.

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Prosocial Behavior in University Students After Tennis Course Based On The Experiential Learning Model Intervention
Time Frame: The intervention will last for 8 weeks, with one 90-minute session each week, and outcomes will be measured at the baseline, at the post-intervention stage
The primary outcome measure is the improvement in prosocial behavior of university students who participated in the tennis course based on the experiential learning model. This will be assessed through the PABSS Chinese version questionnaire , focusing on teamwork, cooperation, social responsibility,
The intervention will last for 8 weeks, with one 90-minute session each week, and outcomes will be measured at the baseline, at the post-intervention stage
Physical Literacy in University Students After Experiential Learning-Based Tennis Course"
Time Frame: The physical literacy outcomes will be measured at the baseline and post-intervention stage (week 8).
The primary outcome measure for physical literacy is the improvement in students' overall physical health and fitness after participating in the tennis course based on the experiential learning model. The CAPL-2 Chinese version questionnaire will be used to assess physical literacy based on various aspects of physical health and fitness.
The physical literacy outcomes will be measured at the baseline and post-intervention stage (week 8).

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Han Xu

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
September 25, 2025

Primary Completion (Actual)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
December 12, 2025

Study Completion (Actual)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
December 12, 2025

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
February 2, 2026

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
February 6, 2026

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
February 11, 2026

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
February 11, 2026

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
February 6, 2026

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
February 1, 2026

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • YXYLL -2025- 120

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings